MwanzoBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
Bei iliyotangulia
$ 0.91
Bei za siku
$ 0.87 - $ 0.93
Bei za mwaka
$ 0.65 - $ 2.45
Thamani ya kampuni katika soko
35.50M USD
Wastani wa hisa zilizouzwa
elfu 34.78
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 20.30M | 250.87% |
Mapato halisi | -19.65M | -26.85% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.49 | -22.50% |
EBITDA | -18.26M | -14.94% |
Asilimia ya kodi ya mapato | 0.11% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 99.12M | -23.74% |
Jumla ya mali | 142.00M | -28.82% |
Jumla ya dhima | 26.40M | -3.87% |
Jumla ya hisa | 115.59M | — |
hisa zilizosalia | 40.27M | — |
Uwiano wa bei na thamani | 0.32 | — |
Faida inayotokana na mali | -33.57% | — |
Faida inayotokana mtaji | -37.64% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -19.65M | -26.85% |
Pesa kutokana na shughuli | -14.90M | -26.05% |
Pesa kutokana na uwekezaji | elfu -5.00 | 98.38% |
Pesa kutokana na ufadhili | elfu 2.00 | -99.60% |
Mabadiliko halisi ya pesa taslimu | -11.82M | 2.46% |
Mtiririko huru wa pesa | -10.07M | -72.81% |
Kuhusu
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Ilianzishwa
2016
Tovuti
Wafanyakazi
105
